Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

10.70
BATS BZX Real-Time Price
As of 10:40am ET
 -0.14 / -1.29%
Today’s Change
3.91
Today|||52-Week Range
11.72
+23.84%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close10.84
Today’s open11.07
Day’s range10.67 - 11.07
Volume18,144
Average volume (3 months)1,328,048
Market cap$760.9M
Dividend yield--
Data as of 10:40am ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-505.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+700.24%
P/E ratio71.5
Price/Sales8.73
Price/Book7.26

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.55+2.59%
AKAOAchaogen Inc-0.21-0.96%
HRTXHeron Therapeutics I...-0.30-2.05%
INSYINSYS Therapeutics I...-0.23-2.08%
Data as of 10:40am ET, 03/28/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Vice President-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs